Evaluation of Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus

被引：0
|
作者：
Reingold, Jason S.
Nasir, Khurram
Patel, Neel R.
Pourfarzib, Ray
Winegar, Deborah
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2413-PO
引用
收藏
页码：A614 / A615
页数：2
相关论文
共 50 条
  • [21] Cardiovascular risk assessment in type 2 diabetes mellitus
    Ebaa Al-Ozairi
    R. Jan-Willem Middelbeek
    Edward S. Horton
    Current Diabetes Reports, 2006, 6 (5)
  • [22] Type 2 diabetes mellitus is not a cardiovascular risk equivalent
    Saely, CH
    Marte, T
    Aczel, S
    Langer, P
    Koch, L
    Schmid, F
    Drexel, H
    DIABETES, 2005, 54 : A182 - A183
  • [23] Cardiovascular risk in the spectrum of type 2 diabetes mellitus
    Ahmed, Intekhab
    Goldstein, Barry J.
    MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (05): : 759 - 768
  • [24] Risk factors for cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients
    Semyatichko, E.
    Nemtsova, V.
    Feclina, I.
    JOURNAL OF NEUROLOGY, 2007, 254 : 110 - 110
  • [25] Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
    Budoff, Matthew J.
    Wilding, John P. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (05)
  • [26] Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus
    Cockcroft, JR
    Wilkinson, IB
    Evans, M
    McEwan, P
    Peters, JR
    Davies, S
    Scanlon, MF
    Currie, CJ
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (11) : 1463 - 1467
  • [27] Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus
    Song, Do Kyeong
    Hong, Young Sun
    Sung, Yeon-Ah
    Lee, Hyejin
    PLOS ONE, 2024, 19 (02):
  • [28] CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH OR WITHOUT METABOLIC SYNDROME
    Millan, J.
    Garcia Calzado, C.
    Recarte, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 29 - 29
  • [29] Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
    Lorber, Daniel
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 169 - 183
  • [30] Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Irons, BK
    Greene, RS
    Mazzolini, TA
    Edwards, KL
    Sleeper, RB
    PHARMACOTHERAPY, 2006, 26 (02): : 168 - 181
12345